| 000 | 01769 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250516051406.0 | ||
| 264 | 0 | _c20120716 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1526-7598 | ||
| 024 | 7 |
_a10.1213/ANE.0b013e318228a001 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBezinover, Dmitri | |
| 245 | 0 | 0 |
_aPerioperative exacerbation of valproic acid-associated hyperammonemia: a clinical and genetic analysis. _h[electronic resource] |
| 260 |
_bAnesthesia and analgesia _cOct 2011 |
||
| 300 |
_a858-61 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aCarbamoyl-Phosphate Synthase (Ammonia) _xdeficiency |
| 650 | 0 | 4 | _aCarbamoyl-Phosphate Synthase I Deficiency Disease |
| 650 | 0 | 4 | _aChronic Disease |
| 650 | 0 | 4 | _aDNA Mutational Analysis |
| 650 | 0 | 4 | _aDevice Removal |
| 650 | 0 | 4 | _aElectric Power Supplies |
| 650 | 0 | 4 | _aGenetic Predisposition to Disease |
| 650 | 0 | 4 | _aHeterozygote |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperammonemia _xchemically induced |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMutation, Missense |
| 650 | 0 | 4 |
_aNeurosurgical Procedures _xadverse effects |
| 650 | 0 | 4 | _aPolymorphism, Single Nucleotide |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aUrea Cycle Disorders, Inborn _xcomplications |
| 650 | 0 | 4 |
_aVagus Nerve Stimulation _xinstrumentation |
| 650 | 0 | 4 |
_aValproic Acid _xadverse effects |
| 700 | 1 | _aPostula, Marek | |
| 700 | 1 | _aDonahue, Kathleen | |
| 700 | 1 | _aBentzen, Brian | |
| 700 | 1 | _aMcInerney, James | |
| 700 | 1 | _aJanicki, Piotr K | |
| 773 | 0 |
_tAnesthesia and analgesia _gvol. 113 _gno. 4 _gp. 858-61 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1213/ANE.0b013e318228a001 _zAvailable from publisher's website |
| 999 |
_c21066402 _d21066402 |
||